Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors.
about
Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Phase 1 study of narnatumab, a ...... ts with advanced solid tumors.
@en
type
label
Phase 1 study of narnatumab, a ...... ts with advanced solid tumors.
@en
prefLabel
Phase 1 study of narnatumab, a ...... ts with advanced solid tumors.
@en
P2093
P2860
P1476
Phase 1 study of narnatumab, a ...... ts with advanced solid tumors.
@en
P2093
Aejaz Nasir
E Gabriela Chiorean
Jan Cosaert
Jennifer Hall
Mrinal Gounder
Nick Loizos
Patricia M LoRusso
Shadia I Jalal
Siva Rama Prasad Kambhampati
P2860
P2888
P304
P356
10.1007/S10637-016-0413-0
P577
2017-02-04T00:00:00Z
P6179
1083537770